Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(MTOX, MJGCF, HFBL, GBLHF, CYBE) Stock in Action by Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

 

 

MEDTOX Scientific Inc. (Nasdaq:MTOX) announced results for the third quarter ended September 30, 2011. Highlights from the quarter compared to the prior-year period include: Total revenues increased 6.9% to $27.6 million. Gross profit increased 5.2% to $11.4 million. Operating expenses were $9.3 million, an increase of 3.7%. Operating income was $2.1 million, an increase of 12.3%. Net income was $1.3 million, an increase of 15.0%. Earnings per diluted share were $0.15 compared to $0.13. For the nine-month period ended September 30, 2011, revenues were $81.2 million, compared to $72.1 million for the prior-year period. Gross profit was $33.9 million, compared to $29.3 million for the prior-year period. Operating income was $5.5 million, compared to $3.5 million for the prior-year period. The Company recorded net income of $3.5 million, compared to $2.2 million for the prior-year period. Earnings per diluted share were $0.39, compared to $0.25 for the prior-year period.

Read full article and disclaimer at :    http://stock-pr.com/?p=20412